Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001553350-25-000144

Director acquired 81,790 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pacala Mark L Director 2025-11-20 Grant or award +46,296 221,267 D: show line 1 in the form
Pacala Mark L Director 2025-11-20 Grant or award +35,494 256,761 D: show line 2 in the form
Loading xslF345X05/ownership.xml…